Matches in Wikidata for { <http://www.wikidata.org/entity/Q97461345> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q97461345 description "clinical trial" @default.
- Q97461345 description "ensayo clínico" @default.
- Q97461345 description "ensayu clínicu" @default.
- Q97461345 description "klinisch onderzoek" @default.
- Q97461345 description "клінічне випробування" @default.
- Q97461345 description "临床试验" @default.
- Q97461345 name "A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function" @default.
- Q97461345 name "A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function" @default.
- Q97461345 type Item @default.
- Q97461345 label "A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function" @default.
- Q97461345 label "A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function" @default.
- Q97461345 prefLabel "A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function" @default.
- Q97461345 prefLabel "A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function" @default.
- Q97461345 P1050 Q97461345-7F6AF55E-2A87-4802-BE48-0DD1CA6757C2 @default.
- Q97461345 P1132 Q97461345-94C7804E-81B7-4187-96E6-6DB3E5D41D48 @default.
- Q97461345 P1476 Q97461345-87F967B2-1798-4ED6-AF4C-A87023A656A8 @default.
- Q97461345 P1813 Q97461345-A7A6C9B0-D1AA-447B-9BEA-78BB1933A02C @default.
- Q97461345 P2899 Q97461345-A7D92025-E9E4-4730-B730-11DB8D2D5A47 @default.
- Q97461345 P3098 Q97461345-AE6BBB76-20EB-494C-B516-897D367A05A6 @default.
- Q97461345 P31 Q97461345-E903FA2E-E3D5-494A-9079-04EBFA1D5F64 @default.
- Q97461345 P580 Q97461345-57C90A7E-FB79-4462-9793-0C2926A0B02F @default.
- Q97461345 P582 Q97461345-D12ED8C0-E7D8-43CF-9F30-7634A55BC6EF @default.
- Q97461345 P6099 Q97461345-FA60F289-1250-4842-83A0-9BC8AD56F49F @default.
- Q97461345 P8005 Q97461345-B8F94AB2-98C8-4930-9DDE-87DF9B9C3E9F @default.
- Q97461345 P8363 Q97461345-EFB41476-A866-4753-9007-5A1934D5D608 @default.
- Q97461345 P921 Q97461345-469A89EE-2E7D-49B3-8CA1-265C27453523 @default.
- Q97461345 P921 Q97461345-49152CDD-3C5E-4856-8A95-2A40E7164BB2 @default.
- Q97461345 P1050 Q33525 @default.
- Q97461345 P1132 "+20" @default.
- Q97461345 P1476 "A Phase II Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma (HCC) and Impaired Liver Function (Child-Pugh Score B7-8)" @default.
- Q97461345 P1813 "CaboCHILD" @default.
- Q97461345 P2899 "+18" @default.
- Q97461345 P3098 "NCT04454762" @default.
- Q97461345 P31 Q30612 @default.
- Q97461345 P580 "2020-08-01T00:00:00Z" @default.
- Q97461345 P582 "2023-08-01T00:00:00Z" @default.
- Q97461345 P6099 Q42824440 @default.
- Q97461345 P8005 Q76649614 @default.
- Q97461345 P8363 Q78089383 @default.
- Q97461345 P921 Q1072720 @default.
- Q97461345 P921 Q795057 @default.